Pink SheetThe European Medicine Agency’s human medicines committee, the CHMP, has delivered a positive opinion on Bristol Myers Squibb Company / bluebird bio ’s CAR T-cell therapy, Abecma (idecabtagene vicleuc
ScripTakeda Pharmaceutical Co. Ltd. and Ovid Therapeutics, Inc. said they are revising their 2017 partnership to address severe pediatric epilepsies on 3 March, with a new agreement that gives the Japan
ScripA Phase II trial testing Takeda Pharmaceutical Company Limited. and Ovid Therapeutics, Inc. 's first-in-class enzyme cholesterol 24-hydroxylase (CH24H) inhibitor soticlestat in children with the ra
Pink SheetThe complete response letter from the US Food and Drug Administration announced by Nabriva Therapeutics PLC this week should send chills through the drug development community, standing as one of th